Situation · 2026-06-12

PODD — Profile and price weak

Premium Not Shielded by Growth Strength

Updated 2026-06-02 · Ref: Medical Devices

Key metrics — 2026-06-02

Peer score

Quality pct

Valuation pct

52w drawdown

-59.6%

21d vs sector

-21.3%

Peer group

Medical Devices

Situation summary

Insulet’s growth is strong, but the stock premium is fragile. A 33.9% revenue jump hasn’t prevented a -61.3% drawdown. The market treats Insulet as a bet, not a safe haven. Too much volatility for a company this strong.

Published by AssetNext · 2026-05-13

All companies with this signal today

View full list: Profile and price weak →

Related pages for PODD

Full peer analysis for Insulet Corporation →Similar companies to PODD PODD peers All PODD comparisons S&P 500 context

Signal history — last 30 days

Date	Signal	Peer score	Drawdown	21d vs sector
2026-06-02	Profile and price weak	55	-59.6%	-21.3%
2026-05-27	Profile and price weak	55	-58.6%	-22.3%
2026-05-27	Profile and price weak	55	-58.6%	-18.3%

See PODD's full peer analysis

Break down PODD's structural position across all peer dimensions with the interactive app.

Open PODD in AssetNext →